Rachel Manahan

Rachel Manahan (Weber), Ph.D., is a seasoned professional in the field of neuroscience with extensive experience in medical science liaison roles at Neurocrine Biosciences and Alder Biopharmaceuticals Inc. Currently serving as a Senior Medical Science Liaison at Neurocrine Biosciences since 2020, Rachel focuses on congenital adrenal hyperplasia and rare pediatric epilepsy. Previous roles include Medical Science Liaison, where expertise was demonstrated in tardive dyskinesia and Parkinson's disease, as well as medical communications management at Alder Biopharmaceuticals. With a strong academic background, including a Ph.D. in Neuroscience from the Medical University of South Carolina, Rachel has contributed significantly to scientific publications, training programs, and internal communications, alongside mentoring emerging scientists. Rachel's research encompasses advanced methodologies in pharmacology and imaging techniques, supporting a robust understanding of clinical and basic research in neurology and psychiatry.